{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:23:08Z","timestamp":1787653388161,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajog.2020.10.028","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T08:40:42Z","timestamp":1618908042000},"page":"S1037-S1047.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"S","title":["Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction"],"prefix":"10.1016","volume":"226","author":[{"given":"Anne","family":"Dathan-Stumpf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Czarnowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Andraczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Stepan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.10.028_bib1","unstructured":"Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015\/018). Hypertensive pregnancy disorders: diagnosis and therapy. 2019. Available at: https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/015-018l_S2k_Diagnostik_Therapie_hypertensiver_Schwangerschaftserkrankungen_2019-07.pdf. Accessed February 12,\u00a02020."},{"key":"10.1016\/j.ajog.2020.10.028_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.10.028_bib4","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1055\/s-0035-1557924","article-title":"Diagnosis and treatment of hypertensive pregnancy disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015\/018, December 2013)","volume":"75","author":"Stepan","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.ajog.2020.10.028_bib5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.10.028_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.10.028_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.028_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2393-14-292","article-title":"Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFlt-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis","volume":"14","author":"Stubert","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2020.10.028_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.028_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.028_bib11","first-page":"A8","article-title":"Technical performance of the first fully automated assays for human soluble fms-like tyrosine kinase 1 and human placental growth factor","volume":"213","author":"Schneider","year":"2009","journal-title":"Z\u00a0Geburtshilfe Neonatol"},{"key":"10.1016\/j.ajog.2020.10.028_bib12","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PlGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.028_bib13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jval.2017.03.008","article-title":"(on behalf of GetReal Work Package 1). What is real-world data? A review of definitions based on literature and stakeholder interviews","volume":"20","author":"Makady","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.ajog.2020.10.028_bib15","author":"Celine"},{"key":"10.1016\/j.ajog.2020.10.028_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/1471-2393-14-324","article-title":"Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol","volume":"14","author":"Hund","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2020.10.028_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/uog.20346","article-title":"Biomarkers of impaired placentation at 35-37 weeks\u2019 gestation in the prediction of adverse perinatal outcome","volume":"54","author":"Ciobanou","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.028_bib18","author":"Sass"},{"key":"10.1016\/j.ajog.2020.10.028_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3109\/14767058.2014.928689","article-title":"Maternal outcomes according to mode of delivery in women with severe preeclampsia: a cohort study","volume":"28","author":"Amorim","year":"2015","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.10.028_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/10641955.2013.874440","article-title":"The complication and mode of delivery in Chinese women with severe preeclampsia: a retrospective study","volume":"33","author":"Zhang","year":"2014","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.10.028_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/uog.19111","article-title":"Screening for pre-eclampsia at 35-37\u2009weeks\u2019 gestation","volume":"52","author":"Panaitescu","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.028_bib23","doi-asserted-by":"crossref","first-page":"486.e1","DOI":"10.1016\/j.ajog.2019.01.227","article-title":"Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks\u2019 gestation","volume":"220","author":"Ciobanu","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.028_bib24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/s-0035-1570379","article-title":"Role of the placenta in preterm birth: a review","volume":"33","author":"Morgan","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2020.10.028_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.10.028_bib26","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.028_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/uog.13224","article-title":"Uterine artery Doppler and sFlt-1\/PlGF ratio: prognostic value in early-onset pre-eclampsia","volume":"43","author":"G\u00f3mez-Arriaga","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.028_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.10.028_bib29","doi-asserted-by":"crossref","first-page":"584.e1","DOI":"10.1016\/j.ajog.2019.01.235","article-title":"Prediction of imminent preeclampsia at 35-37 weeks gestation","volume":"220","author":"Ciobanu","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.10.028_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.119.13997","article-title":"Angiogenic marker prognostic models in pregnant women with hypertension","volume":"75","author":"Perry","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.10.028_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/uog.17307","article-title":"Comparison of screening for pre-eclampsia at 31-34 weeks\u2019 gestation by sFlt-1\/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF","volume":"49","author":"Tan","year":"2017","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820312023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820312023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:33:14Z","timestamp":1757590394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820312023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0002937820312023"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.10.028","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}